Abstract
Claudins (CLDN) are tight junction proteins which contribute to the paracellular transport and ionic permeability of various epithelia. In recent years they came into focus for their suggested role in carcinogenesis and possible role in cancer therapy. According to our previous studies, in breast tissue CLDN4 is also related to the level of cellular differentiation. Thirty-eight estrogen (ER) and progesterone receptor (PgR) negative, HER2/neu negative, but cytokeratin 5/6 positive basal-like—mainly grade 3—breast carcinomas were compared with twenty-one grade 1, twenty-five grade 2 and twenty grade 3 non-basal-like invasive breast carcinomas, in respect to their CLDN4 expression. The immunohistochemical reactions were evaluated both semiquantitatively and by morphometrical analysis. Statistically significant difference (p = 0.001) was observable regarding CLDN4 expression in the basal-like group as compared to grade 1 and 2 cancers. Further, CLDN4 expression was significantly higher (p = 0.017) in the basal-like compared with the non-basal-like grade 3 carcinomas. Our results suggest that basal-like carcinomas are a subset of breast cancer with high level of CLDN4 protein expression. The finding is in accordance with our former observation that CLDN4 is indeed related to cellular differentiation. This observation may be seen as a further proof that basal-like carcinomas represent a separable group amongst grade 3 breast carcinomas.
Similar content being viewed by others
Abbreviations
- CLDN4:
-
claudin-4
- EGFR:
-
epidermal growth factor receptor
- ER:
-
estrogen receptor
- FFPE:
-
formalin-fixed, paraffin-embedded
- FISH:
-
fluorescent in-situ hybridisation
- PgR:
-
progesterone receptor
- TMA:
-
tissue microarray
References
Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752
Fulford LG, Reis-Filho JS, Ryder K et al (2007) Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival. Breast Cancer Res 9:R4, doi:10.1186/bcr1636
Banerjee S, Reis-Filho JS, Ashley S et al (2006) Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol 59:729–735
Hu Z, Fan C, Oh DS et al (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96
Sorlie T (2007) Molecular classification of breast tumors: toward improved diagnostics and treatments. Methods Mol Biol 360:91–114
Da Silva L, Clarke C, Lakhani SR (2007) Demystifying basal-like breast carcinomas. J Clin Pathol 60:1328–1332
Bryan BB, Schnitt SJ, Collins LC (2006) Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Path 19:617–621
Buerger H, Otterbach F, Simon R et al (1999) Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Path 189:521–526
Kondoh M (2006) Claudin as a novel target for drug delivery system. Yakugaku Zasshi 126:711–721
Tokes AM, Kulka J, Paku S et al (2005) The expression of five different claudins in invasive breast carcinomas: comparison of pT1pN1 and pT1pN0 tumors. Pathol Res Pract 201:537–544
Tokes AM, Kulka J, Paku S et al (2005) Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7:R296–R305
Furuse M, Fujita K, Hiiragi T et al (1998) Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141:1539–1550
Sobel G, Paska C, Szabo I et al (2005) Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Human Pathol 36:162–169
Sobel G, Nemeth J, Kiss A et al (2006) Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma. Gynecol Oncol 103:591–598
Michl P, Barth C, Buchholz M et al (2003) Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 63:6265–6271
Michl P, Buchholz M, Rolke M et al (2001) Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 121:678–684
Garcia S, Dales JP, Charafe-Jauffret E et al (2007) Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype. Human Pathol 38:830–841
Livasy CA, Karaca G, Nanda R et al (2006) Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Path 19:264–271
Acknowledgements
We thank Pekár Zoltánné and Azumah Francisné for preparing the TMA-s and the immunohistochemical reactions. We thank also Rigóné Kálé Elvira for careful reading and correction of the manuscript.
Competing interests
The authors declare no competing interests. The study was reviewed and approved by the Institutional Ethical Board under the licence number 172/2003.
Author information
Authors and Affiliations
Corresponding author
Additional information
Janina Kulka and Attila Marcell Szász have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Kulka, J., Szász, A.M., Németh, Z. et al. Expression of Tight Junction Protein Claudin-4 in Basal-Like Breast Carcinomas. Pathol. Oncol. Res. 15, 59–64 (2009). https://doi.org/10.1007/s12253-008-9089-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-008-9089-x